Company news
Acrux Limited (ASX:ACR) news
Acrux Limited news releases on 6ix. Latest, Feb 1, 2018: Axiron Net Sales Quarter to December 2017
Press releases — page 3
Axiron Net Sales Quarter to December 2017
January 31, 2018
Axiron Patents Appeal Decision
November 22, 2017
Axiron Net Sales Quarter to September 2017
October 24, 2017
Axiron License Agreement Terminated
September 5, 2017
Appendix 4E and 2017 Financial Report
August 22, 2017
Teva Launches Generic Version of Axiron in United States
August 21, 2017
Axiron Net Sales Quarter to 30 June 2017
July 25, 2017
Axiron Generic Launched In The United States
July 6, 2017
Institution of IPR Proceeding Against Key Jublia Patent
May 2, 2017
Axiron Net Sales Quarter to 31 March 2017
April 25, 2017
Appendix 4D and Half Year Report to 31 December 2016
February 17, 2017
Axiron Net Sales, Quarter to December2016
January 31, 2017
S&P DJ Indices Announces March Quarterly Review
November 7, 2016
European approvals and milestone payments for Lenzetto
November 6, 2016
IPR Petition Filed Against Key Jublia Patent
November 2, 2016
NEW INTELLECTUAL PROPERTY APPLICATION FOR ONYCHOMYCOSIS
November 1, 2016
Axiron Net Sales, Quarter to September 2016
October 25, 2016
Acrux announces 2016 financial results
August 24, 2016
Acrux announces court ruling on Axiron patent families
August 23, 2016
Axiron Net Sales, quarter to June 2016
July 26, 2016
Acrux generic strategy and Axiron patent litigation update
June 30, 2016
Axiron Net Sales, quarter to March 2016
April 26, 2016
Acrux Appendix 4D - December 2015
February 24, 2016
Axiron Net Sales, quarter to 31 December 2015
February 11, 2016
Axiron Net Sales, quarter to September 2015
February 10, 2016